Next Article in Journal
Targeted Molecular Imaging Using Aptamers in Cancer
Next Article in Special Issue
Ketamine and Ceftriaxone-Induced Alterations in Glutamate Levels Do Not Impact the Specific Binding of Metabotropic Glutamate Receptor Subtype 5 Radioligand [18F]PSS232 in the Rat Brain
Previous Article in Journal
In Silico SAR Studies of HIV-1 Inhibitors
Previous Article in Special Issue
Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors—An Improvement for Breast Cancer Imaging?
Open AccessArticle

Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara 44121, Italy
Department of Physic and Earth Science, University of Ferrara, Ferrara 44122, Italy
Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara 44121, Italy
Author to whom correspondence should be addressed.
Pharmaceuticals 2018, 11(3), 70;
Received: 15 June 2018 / Revised: 11 July 2018 / Accepted: 12 July 2018 / Published: 16 July 2018
Background: New approaches based on the receptor-targeted molecular interaction have been recently developed with the aim to investigate specific probes for sentinel lymph nodes. In particular, the mannose receptors expressed by lymph node macrophages became an attractive target and different multifunctional mannose derivate ligands for the labeling with 99mTc have been developed. In this study, we report the synthesis of a specific class of dextran-based, macromolecular, multifunctional ligands specially designed for labeling with the highly stable [99mTc≡N]2+ core. Methods: The ligands have been obtained by appending to a macromolecular dextran scaffold pendant arms bearing a chelating moiety for the metallic group and a mannosyl residue for allowing the interaction of the resulting macromolecular 99mTc conjugate with specific receptors on the external membrane of macrophages. Two different chelating systems have been selected, S-methyl dithiocarbazate [H2N‒NH‒C(=S)SCH3=HDTCZ] and a sequence of two cysteine residues, that in combination with a monophosphine coligand, are able to bind the [99mTc≡N]2+ core. Conclusions: High-specific-activity labeling has been obtained by simple mixing and heating of the [99mTc≡N]2+ group with the new mannose-dextran derivatives. View Full-Text
Keywords: sentinel lymph node; dextran; mannose; 99mTc-radiopharmaceuticals sentinel lymph node; dextran; mannose; 99mTc-radiopharmaceuticals
Show Figures

Figure 1

MDPI and ACS Style

Boschi, A.; Pasquali, M.; Trapella, C.; Massi, A.; Martini, P.; Duatti, A.; Guerrini, R.; Zanirato, V.; Fantinati, A.; Marzola, E.; Giganti, M.; Uccelli, L. Design and Synthesis of 99mTcN-Labeled Dextran-Mannose Derivatives for Sentinel Lymph Node Detection. Pharmaceuticals 2018, 11, 70.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop